Decline in Residual Renal Function in Automated Compared with Continuous Ambulatory Peritoneal Dialysis

作者：Michels Wieneke Marleen^*; Verduijn Marion; Grootendorst Diana C; le Cessie Saskia; Boeschoten Elisabeth Wilhelmina; Dekker Friedo Wilhelm; Krediet Raymond Theodorus

来源：Clinical Journal of the American Society of Nephrology, 2011, 6(3): 537-542.

DOI：10.2215/CJN.00470110

Background and objectives We compared the decline of RRF in patients starting dialysis on APD with those starting on CAPD, because a faster decline on APD has been suggested.
Design, setting, participants, & measurements NECOSAD patients starting dialysis on APD or CAPD with RRF at baseline were included and followed for 3 years. Residual GFR (rGFR) was the mean of urea and creatinine clearances. Differences in yearly decline of rGFR were estimated in analyses with linear repeated measures models, whereas the risk of complete loss of RRF was estimated by calculating hazard ratios (HRs) for APD compared with CAPD. As-treated (AT) and intention-to-treat (ITT) designs were used. All of the analyses were adjusted for age, gender, comorbidity, and primary kidney disease and stratified according to follow-up and mean baseline GFR.
Results The 505 CAPD and 78 APD patients had no major baseline differences. No differences were found in the analyses on yearly decline of rGFR. APD patients did have a higher risk of losing RRF in the first year (ITT crude HR 2.43 [confidence interval 95%, 1.48 to 4.00], adjusted 2.66 [1.60 to 4.44]; AT crude 1.89 [1.04 to 3.45], adjusted 2.15 [1.16 to 3.98]). The higher risk of losing all RRF was most pronounced in patients with the highest rGFR at baseline (ITT; crude 3.91 [1.54 to 9.94], adjusted 1.85 to 14.17).
Conclusions The risk of losing RRF is higher for patients starting dialysis on APE) compared with those starting on CAPD, especially in the first year. Clin J Am Soc Nephrol 6: 537-542, 2011. doi: 10.2215/CJN.00470110

• 出版日期2011-3